The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood
Open accessAbstract
Summary: Objective: Epilepsy is a common neurologic disorder of childhood. To determine the genetic diagnostic yield in epileptic encephalopathy, we performed a retrospective cohort study in a single epilepsy genetics clinic. Methods: We included all patients with intractable epilepsy, global developmental delay, and cognitive dysfunction seen between January 2012 and June 2014 in the Epilepsy Genetics Clinic. Electronic patient charts were reviewed for clinical features, neuroimaging, biochemical investigations, and molecular genetic investigations including targeted next‐generation sequencing of epileptic encephalopathy genes. Results: Genetic causes were identified in 28% of the 110 patients: 7% had inherited metabolic disorders including pyridoxine dependent epilepsy caused byALDH 7A1 mutation, Menkes disease, pyridox(am)ine‐5‐phosphate oxidase deficiency, cobalamin G deficiency, methylenetetrahydrofolate reductase deficiency, glucose transporter 1 deficiency, glycine encephalopathy, and pyruvate dehydrogenase complex deficiency; 21% had other genetic causes including genetic syndromes, pathogenic copy number variants on array comparative genomic hybridization, and epileptic encephalopathy related to mutations in theSCN 1A,SCN 2A,SCN 8A,KCNQ 2,STXBP 1,PCDH 19, andSLC 9A6 genes. Forty‐five percent of patients obtained a genetic diagnosis by targeted next‐generation sequencing epileptic encephalopathy panels. It is notable that 4.5% of patients had a treatable inherited metabolic disease. Significance: To the best of our knowledge, this is the first study to combine inherited metabolic disorders and other genetic causes of epileptic encephalopathy. Targeted next‐generation sequencing panels increased the genetic diagnostic yield from <10% to >25% in patients with epileptic encephalopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R. F., Deprez, L., Smets, K., Hristova, D., Yordanova, I., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22644 · Cited by 514
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.013 · Cited by 439
Veeramah, K. R., O'Brien, J. E., Meisler, M. H., Cheng, X., Dib-Hajj, S. D., Waxman, S. G., Talwar, D., Girirajan, S., Eichler, E. E., Restifo, L. L., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.01.006 · Cited by 438
Weber, Y. G., Storch, A., Wuttke, T. V., Brockmann, K., Kempfle, J., Maljevic, S., Margari, L., Kamm, C., Schneider, S. A., Huber, S. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34438 · Cited by 363
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients
Depienne, C., Trouillard, O., Saint-Martin, C., Gourfinkel-An, I., Bouteiller, D., Carpentier, W., Keren, B., Abert, B., Gautier, A., Baulac, S., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062323 · Cited by 363
Targeted next generation sequencing as a diagnostic tool in epileptic disorders
Lemke, J. R., Riesch, E., Scheurenbrand, T., Schubach, M., Wilhelm, C., Steiner, I., Hansen, J., Courage, C., Gallati, S., Bürki, S., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03516.x · Cited by 332
Exome sequencing reveals new causal mutations in children with epileptic encephalopathies
Veeramah, K. R., Johnstone, L., Karafet, T. M., Wolf, D., Sprissler, R., Salogiannis, J., Barth‐Maron, A., Greenberg, M. E., Stuhlmann, T., Weinert, S., et al. (2013) · Epilepsia · doi:10.1111/epi.12201 · Cited by 293
Martin, H. C., Kim, G. E., Pagnamenta, A. T., Murakami, Y., Carvill, G. L., Meyer, E., Copley, R. R., Rimmer, A., Barcia, G., Fleming, M. R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu030 · Cited by 258
Rare copy number variants are an important cause of epileptic encephalopathies
Mefford, H. C., Yendle, S. C., Hsu, C., Cook, J., Geraghty, E., McMahon, J. M., Eeg‐Olofsson, O., Sadleir, L. G., Gill, D., Ben‐Zeev, B., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22645 · Cited by 247
Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome
Nakamura, K., Kato, M., Osaka, H., Yamashita, S., Nakagawa, E., Haginoya, K., Tohyama, J., Okuda, M., Wada, T., Shimakawa, S., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e57 · Cited by 201
Burden of Epilepsy: The Ontario Health Survey
Wiebe, S., Eliasziw, M., Bellhouse, D. R., & Fallahay, C. (1999) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000354 · Cited by 188
The genetic landscape of infantile spasms
Michaud, J. L., Lachance, M., Hamdan, F. F., Carmant, L., Lortie, A., Diadori, P., Major, P., Meijer, I. A., Lemyre, E., Cossette, P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu199 · Cited by 185
Idiopathic Epilepsies with Seizures Precipitated by Fever and SCN1A Abnormalities
Marini, C., Mei, D., Temudo, T., Ferrari, A. R., Buti, D., Dravet, C., Dias, A. I., Moreira, A., Calado, E., Seri, S., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01122.x · Cited by 177
Copy number variation plays an important role in clinical epilepsy
Olson, H., Shen, Y., Avallone, J., Sheidley, B. R., Pinsky, R., Bergin, A. M., Berry, G. T., Duffy, F. H., Eksioglu, Y., Harris, D. J., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24178 · Cited by 174
Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations
Deprez, L., Weckhuysen, S., Holmgren, P., Suls, A., Van Dyck, T., Goossens, D., Del-Favero, J., Jansen, A., Verhaert, K., Lagae, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f4d7bf · Cited by 166
Early onset epileptic encephalopathy caused by de novo SCN 8A mutations
Ohba, C., Kato, M., Takahashi, S., Lerman‐Sagie, T., Lev, D., Terashima, H., Kubota, M., Kawawaki, H., Matsufuji, M., Kojima, Y., et al. (2014) · Epilepsia · doi:10.1111/epi.12668 · Cited by 158
PCDH19-related infantile epileptic encephalopathy: An unusual X-linked inheritance disorder
Depienne, C., & Leguern, É. (2012) · Human Mutation · doi:10.1002/humu.22029 · Cited by 140
Milh, M., Villeneuve, N., Chouchane, M., Kamińska, A., Laroche, C., Barthez, M. A., Gitiaux, C., Bartoli, C., Borges-Correia, A., Cacciagli, P., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03181.x · Cited by 131
Etiology and clinical predictors of intractable epilepsy
Chawla, S., Aneja, S., Kashyap, R., & Mallika, V. (2002) · Pediatric Neurology · doi:10.1016/s0887-8994(02)00416-2 · Cited by 107
Milh, M., Boutry‐Kryza, N., Sutera-Sardo, J., Mignot, C., Auvin, S., Lacoste, C., Villeneuve, N., Roubertie, A., Héron, B., Carneiro, M., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-80 · Cited by 107
Dyment, D. A., Tétreault, M., Beaulieu, C. L., Hartley, T., Ferreira, P. C., Warman‐Chardon, J., Marcadier, J., Sawyer, S. L., Mosca, S. J., Innes, A. M., et al. (2014) · Clinical Genetics · doi:10.1111/cge.12464 · Cited by 95
Refining the phenotype of α‐1a Tubulin (TUBA1A) mutation in patients with classical lissencephaly
Morris-Rosendahl, D. J., Najm, J., Lachmeijer, A. M. A., et al. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01093.x · Cited by 92
Epilepsy in inborn errors of metabolism
Wolf, N. I., Bast, T., & Surtees, R. A. H. (2005) · Epileptic Disorders · doi:10.1684/j.1950-6945.2005.tb00106.x · Cited by 86
Kodera, H., Kato, M., Nord, A. S., Walsh, T., Lee, M. J., Yamanaka, G., Tohyama, J., Nakamura, K., Nakagawa, E., Ikeda, T., et al. (2013) · Epilepsia · doi:10.1111/epi.12203 · Cited by 86
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform
Mina, E. D., Ciccone, R., Brustia, F., Bayindir, B., Limongelli, I., Vetro, A., Iascone, M. R., Pezzoli, L., Bellazzi, R., Perotti, G., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.92 · Cited by 83
MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features
Auranen, M., Vanhala, R., Vosman, M., Levander, M., Varilo, T., Hietala, M., Riikonen, R., Peltonen, L., & Järvelä, I. E. (2001) · Neurology · doi:10.1212/wnl.56.5.611 · Cited by 78
Diagnostic Yield of Clinical Next-Generation Sequencing Panels for Epilepsy
Wang, J., Gotway, G. K., Pascual, J. M., & Park, J. Y. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.405 · Cited by 70
Glucose Transporter Type 1 Deficiency Syndrome
Akman, C. I., & Vivo, D. C. D. (2018) · Springer Publishing Company eBooks · doi:10.1891/9780826168641.0023 · Cited by 66
SCN1A-Related Seizure Disorders
Miller, I., & de Menezes, M. A. S. (2014) · Cited by 23
Cited by
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders
Wolff, M., Johannesen, K. M., Hedrich, U. B. S., Masnada, S., Rubboli, G., Gardella, E., Lesca, G., Ville, D., Milh, M., Villard, L., et al. (2017) · Brain · doi:10.1093/brain/awx054 · Cited by 600
Helbig, K. L., Farwell Hagman, K. D., Shinde, D. N., Mroske, C., Powis, Z., Li, S., Tang, S., & Helbig, I. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.186 · Cited by 363
STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy
Stamberger, H., Nikanorova, M., Willemsen, M. H., Accorsi, P., Angriman, M., Baier, H., Benkel-Herrenbrueck, I., Benoit, V., Budetta, M., Caliebe, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002457 · Cited by 317
Lindy, A. S., Stosser, M. B., Butler, E., Downtain‐Pickersgill, C., Shanmugham, A., Retterer, K., Brandt, T., Richard, G., & McKnight, D. A. (2018) · Epilepsia · doi:10.1111/epi.14074 · Cited by 305
Metadata
- Authors
- Mercimek‐Mahmutoglu, S., Patel, J., Cordeiro, D., Hewson, S., Callen, D., Donner, E. J., Hahn, C. D., Kannu, P., Kobayashi, J., Minassian, B. A., Moharir, M., Siriwardena, K., Weiss, S. K., Weksberg, R., & Snead, O. C.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2015-03-25
- Volume
- 56
- Issue
- 5
- Pages
- 707-716
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2065972516
- Cited by
- 258
- References
- 33
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.